ELV Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

03
Cena $400.09
Kapitalizacja Rynkowa (MRQ) $86.76B
P/E (TTM) 17.7
EPS (TTM) $22.59
Przychody (TTM) $201.11B
Stopa dywidendy 1.7%
ROE (TTM) 11.2%
D/E Dług/Kapitał (MRQ) 0.7
Zakres 52 tyg. $275–$436

ELV Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

04
zakres
kreski

Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.

Podziały akcji 1
Data ex-dywidendy Podział Typ
1 czerwca 2005 2-for-1 Naprzód

O Elevance Health, Inc. Common Stock Przegląd firmy z Wikipedii

05 · wikidata

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second-largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

sektorHealth Care branżaHealth Care pracownicy96 129 krajUS

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

06
Przychody$199.12B
2016-12-31 → 2025-12-31
EPS$25.21
2016-12-31 → 2025-12-31
Wolny przepływ pieniężny$3.17B
2016-12-31 → 2025-12-31
Marża netto2.5%
2016-12-31 → 2025-12-31
Wycena i wskaźniki 07–12

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik Trend 5-letni ELV średnia z 5 lat Mediana porównawcza Werdykt
P/E (TTM) 17.7średnia z 5 lat ≈17.3 ≈17.3 36.3 Niedowartościowany
P/S (TTM) 0.4średnia z 5 lat ≈0.6 ≈0.6 0.7 Niedowartościowany
P/B (MRQ) 1.9średnia z 5 lat ≈2.6 ≈2.6 3.9 Niedowartościowany
EV / EBITDA 12.7średnia z 5 lat ≈12.8 ≈12.8 16.1 Niedowartościowany
Cena / FCF (TTM) 13.8średnia z 5 lat ≈18.3 ≈18.3 · ·
Cena / Przepływy pieniężne (TTM) 11.6średnia z 5 lat ≈14.8 ≈14.8 15.6 Zawyżona wycena
EV / Revenue (EV / Przychody) 0.6średnia z 5 lat ≈0.7 ≈0.7 · ·
EV / FCF 34.9średnia z 5 lat ≈22.2 ≈22.2 · ·
Cena / Wartość księgowa materialna (MRQ) 2.6średnia z 5 lat ≈61.0 ≈61.0 · ·
PEG Ratio (Współczynnik PEG) ≈2.5 · · ·

Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.

wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

13
Stopa Dywidendy1.7%
Wskaźnik Wypłaty Dywidendy27.0%
Zannualizowane wypłaty≈$6.88Płatne kwartalnie
CAGR dywidendy 5-letni≈12.5%Na akcję, skorygowane o podział
Seria wzrostów≈13Kolejne lata wzrostu dywidendy
Data ex-dywidendyKwotaWalutaStopa zwrotu
Wrz 10, 2026$1,72USD≈1.6%
Cze 10, 2026$1,72USD≈1.7%
Mar 10, 2026$1,72USD≈2.4%
Gru 5, 2025$1,71USD≈2.1%
Wrz 10, 2025$1,71USD≈2.2%
Cze 10, 2025$1,71USD≈1.7%
Mar 10, 2025$1,71USD≈1.6%
Gru 5, 2024$1,63USD≈1.7%
Wrz 10, 2024$1,63USD≈1.2%
Cze 10, 2024$1,63USD≈1.2%
Mar 7, 2024$1,63USD≈1.2%
Gru 5, 2023$1,48USD≈1.2%
Wrz 7, 2023$1,48USD≈1.3%
Cze 8, 2023$1,48USD≈1.2%
Mar 9, 2023$1,48USD≈1.2%
Gru 2, 2022$1,28USD≈0.98%
Wrz 8, 2022$1,28USD≈1.0%
Cze 9, 2022$1,28USD≈0.99%
Mar 9, 2022$1,28USD≈1.0%
Gru 2, 2021$1,13USD≈1.1%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

14
Średnie zaskoczenie 10.5%
Następny raport Paź 19, 2026
OkresRaportEPS ActualEPS SzacowanyNiespodzianka
30 czerwca 2026 Lip 15, 2026 $7.45 $6.27 18.9%
31 marca 2026 $12.58 $10.93 15.1%
31 grudnia 2025 $3.33 $3.13 6.5%
30 września 2025 $6.03 $4.98 21.0%
30 czerwca 2025 $8.84 $9.04 -2.3%
31 marca 2025 $11.97 $11.50 4.1%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

15
Rachunek zysków i strat 13
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue $199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B$79.16B$73.87B
Cost of Revenue $21.18B$19.75B$17.29B$13.04B$10.89B$8.95B$1.99B$0$0···
SG&A Expense $20.98B$20.02B$20.09B$17.70B$15.92B$17.45B$13.36B$14.02B$12.65B$12.56B$12.53B$11.75B
Operating Income $7.20B$7.86B$8.50B$8.28B$7.56B$6.36B$6.00B$5.43B$4.17B$4.80B$4.75B$4.42B
Interest Expense ··$1.03B$851M$798M$784M$746M$753M$739M$723M$653M$601M
Pretax Income $6.71B$7.90B$7.71B$7.60B$8.00B$6.24B$5.99B$5.07B$3.96B$4.55B$4.63B$4.37B
Income Tax $1.05B$1.93B$1.72B$1.71B$1.85B$1.67B$1.18B$1.32B$121M$2.08B$2.07B$1.81B
Net Income $5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B$2.56B$2.57B
EPS (Basic) $25.28$25.81$25.38$24.56$25.26$18.23$18.81$14.53$14.70$9.39$9.73$9.31
EPS (Diluted) $25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99
Shares (Basic) 224,000,000231,700,000235,900,000240,000,000243,800,000250,800,000255,500,000258,100,000261,500,000262,900,000263,000,000275,900,000
Shares (Diluted) 224,600,000232,900,000237,400,000242,800,000246,800,000254,300,000260,300,000264,200,000267,800,000268,100,000272,900,000285,900,000
EBITDA $8.74B$9.26B$10.24B$10.13B$8.79B$7.51B$6.00B$5.43B$4.18B$4.80B$4.75B$4.42B
Bilans 26
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $9.49B$8.29B$6.53B$7.39B$4.88B$5.74B$4.94B$3.93B$3.61B$4.08B$2.11B$2.15B
Other Current Assets $5.34B$4.70B$5.79B$5.28B$4.65B$4.06B$3.02B$2.10B$2.25B$1.78B$1.56B$1.47B
Current Assets $63.00B$58.94B$60.03B$55.62B$51.12B$45.75B$39.03B$34.32B$36.26B$34.31B$30.86B$31.95B
PP&E (Net) $4.68B$4.65B$4.36B$4.32B$3.92B$3.48B$3.13B$2.73B$2.17B$1.98B$2.02B$1.94B
PP&E (Gross) $8.73B$8.33B$7.90B$7.12B$8.26B$7.33B$6.48B$5.55B$4.37B$4.14B$4.06B$3.76B
Accum. Depreciation $4.06B$3.68B$3.54B$2.80B$4.34B$3.84B$3.35B$2.81B$2.20B$2.16B$2.04B$1.82B
Goodwill $28.34B$28.28B$25.32B$24.38B$24.23B$21.69B$20.50B$20.50B$19.23B$17.56B$17.56B$17.08B
Intangibles $11.20B$12.09B$10.27B$10.31B$10.62B$9.40B$8.67B$9.01B$8.37B$7.96B$8.16B$7.96B
Other Non-current Assets $2.31B$2.14B$1.97B$1.69B$1.72B$1.44B$1.35B$758M$565M$468M$485M$512M
Total Assets $121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B$61.72B$61.68B
Accounts Payable $7.32B$6.93B$6.91B$5.61B$4.97B$5.49B$4.20B$4.96B$5.02B$4.01B$3.32B$3.65B
Short-term Debt $150M$365M$225M$265M$275M$0$700M$1.15B$1.27B$440M$540M$400M
Current Liabilities $41.03B$40.58B$41.79B$39.70B$34.88B$29.45B$23.53B$21.96B$23.36B$21.29B$19.09B$18.75B
Capital Leases $529M$658M$685M$751M$864M·······
Deferred Tax $2.11B$2.15B$1.97B$2.02B$2.81B$2.02B$2.23B$1.96B$1.73B$2.78B$2.63B$2.95B
Other Non-current Liabilities $3.53B$3.33B$1.74B$1.56B$1.68B$1.81B$1.42B$1.18B$925M$884M$994M$1.04B
Total Liabilities $77.47B$75.46B$69.52B$66.42B$61.29B$53.42B$45.73B$43.03B$44.04B$39.98B$38.67B$37.42B
Long-term Debt $31.90B$30.87B$24.89B$23.85B$22.76B$20.04B$19.39B$18.07B$18.66B$15.29B$15.32B$14.64B
Total Debt $32.05B$31.23B$25.12B$24.11B$23.03B$20.04B$20.09B$19.21B$19.93B$15.73B$15.86B$15.15B
Common Stock $2M$2M$2M$2M$2M$3M$3M$3M$3M$3M$3M$3M
Paid-in Capital $8.94B$8.91B$8.87B$9.08B$9.15B$9.24B$9.45B$9.54B$8.55B$8.81B$8.56B$10.06B
Retained Earnings $35.39B$33.55B$31.75B$29.65B$27.14B$23.80B$22.57B$19.99B$18.05B$16.56B$14.78B$14.01B
AOCI $-451M$-1.15B$-1.31B$-2.49B$-197M$150M$-296M$-986M$-101M$-268M$-293M$172M
Stockholders' Equity $43.88B$41.31B$39.31B$36.24B$36.09B$33.20B$31.73B$28.54B$26.50B$25.10B$23.05B$24.25B
Liabilities + Equity $121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B$61.72B$61.68B
Shares Outstanding 220,723,898227,479,695233,071,088237,958,067241,770,746245,401,430252,922,161257,395,577256,084,913263,747,395261,238,188268,109,932
Przepływy pieniężne 18
Wskaźnik Trend 202520242023202220212020201920182017201620152014
D&A $1.55B$1.39B$1.75B$1.68B$1.30B$1.15B$1.13B$1.13B····
Stock-based Comp $276M$191M$289M$264M$255M$283M$294M$226M$170M$165M$148M$169M
Deferred Tax $-279M$-374M$-602M$-115M$342M$-540M$81M$91M$-1.27B$127M$-66M$31M
Amort. of Intangibles $628M$580M$885M$767M$441M$361M$338M$358M$169M$192M$230M$221M
Other Non-cash $-2.92B$-1.38B$642M$511M$377M$5.22B······
Operating Cash Flow $4.29B$5.81B$8.06B$8.40B$8.36B$10.69B$6.06B$3.83B$4.18B$3.27B$4.21B$3.37B
CapEx $1.12B$1.26B$1.30B$1.15B$1.09B$1.02B$1.08B$1.21B$791M$584M$638M$715M
Investing Cash Flow $-1.34B$-5.17B$-5.57B$-4.56B$-9.64B$-7.32B$-2.79B$-1.26B$-5.08B$-514M$-1.15B$-975M
Debt Issued $2.99B$7.71B$2.57B$3.07B$3.46B$2.48B$2.47B$835M$5.46B$0$1.23B$2.70B
Net Debt Issued $844M$6.06B$665M$1.17B$2.39B$552M$1.35B$-849M$2.64B$0$-1.47B$970M
Stock Issued ·····$0$0$1.25B$0$0··
Stock Repurchased $2.60B$2.90B$2.68B$2.32B$1.90B$2.70B$1.70B$1.69B$2.00B$0$1.52B$3.00B
Net Stock Activity $-2.60B$-2.90B$-2.68B$-2.32B$-1.90B$-2.70B$-1.70B$-435M$-2.00B$0$-1.52B$-3.00B
Dividends Paid $1.53B$1.51B$1.40B$1.23B$1.10B$954M$818M$776M$705M$684M$657M$481M
Financing Cash Flow $-1.74B$1.19B$-3.35B$-1.32B$423M$-2.57B$-2.27B$-2.24B$427M$-799M$-3.09B$-1.82B
Net Change in Cash $1.20B$1.83B$-861M$2.51B$-861M$804M$1.00B$325M$-466M$1.96B$-38M$565M
Free Cash Flow $3.17B$4.55B$6.76B$7.25B$7.28B$9.67B$4.98B$2.62B$3.39B$2.62B$3.48B$2.65B
Levered FCF ··$5.97B$6.59B$6.66B$9.09B$4.38B$2.06B$2.67B$2.23B$3.12B$2.30B
Rentowność 7
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Operating Margin 3.6%4.4%5.0%5.4%5.4%5.2%5.8%5.9%4.6%5.7%6.0%6.0%
Net Margin 2.8%3.4%3.5%3.9%4.4%3.8%4.6%4.1%4.3%2.9%3.2%3.5%
Pretax Margin 3.4%4.5%4.5%5.0%5.7%5.1%5.7%5.5%4.4%5.4%5.9%5.9%
EBITDA Margin 4.4%5.2%6.0%6.5%6.3%6.2%5.8%5.9%4.6%5.7%6.0%6.0%
ROA 4.8%5.3%5.7%6.0%6.6%5.6%6.5%5.3%5.7%3.9%4.2%4.2%
ROE 13.3%14.8%15.8%16.7%17.0%13.6%15.2%13.0%14.6%9.9%11.1%10.6%
ROIC 8.0%8.2%10.2%10.8%9.8%8.8%9.3%8.4%8.7%6.4%6.8%6.6%
Płynność i wypłacalność 5
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Current Ratio 1.51.51.41.41.51.61.71.61.61.61.61.7
Quick Ratio 0.20.20.20.20.10.20.20.20.20.20.10.1
Debt / Equity 0.70.80.60.70.60.60.60.70.80.60.70.6
LT Debt / Equity 0.70.70.60.60.60.60.60.60.70.60.70.6
Interest Coverage ··8.39.99.48.18.07.25.76.67.37.4
Efektywność 1
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Asset Turnover 1.71.61.61.61.51.51.41.31.31.31.31.2
Na akcję 6
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Book Value / Share $198.81$181.62$168.64$152.58$149.15$135.28$125.45$110.88$103.49$95.17$88.21$90.45
Revenue / Share $886.58$760.03$721.74$644.95$561.75$479.23$400.36$348.62$336.22$316.53$290.06$258.39
Cash Flow / Share $19.10$24.94$33.96$34.59$33.89$42.03$23.28$14.49$15.63$11.95$15.08$11.78
Cash / Share $43.00$36.43$28.00$31.04$20.18$23.39$19.52$15.28$14.09$15.45$8.09$8.03
Dividend / Share ··$5.92$5.12$4.52$3.80$3.20$3.00$2.70$2.60$2.50$1.75
EPS (TTM) $25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99
Stopy Wzrostu 10
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue YoY 12.5%3.3%9.4%13.0%13.8%·······
Revenue CAGR 3Y 8.3%8.5%12.0%·········
Revenue CAGR 5Y 10.3%···········
EPS YoY -1.8%1.8%3.9%-2.7%38.8%·······
EPS CAGR 3Y 1.3%0.97%11.9%·········
EPS CAGR 5Y 7.0%···········
Net Income YoY -5.3%-0.12%1.6%-4.3%34.7%·······
Net Income CAGR 3Y -1.3%-0.97%9.4%·········
Net Income CAGR 5Y 4.4%···········
Dividends Paid CAGR 5Y 9.9%···········
Wycena (TTM) 17
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue TTM $199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B$79.16B$73.87B
Net Income TTM $5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B$2.56B$2.57B
Market Cap $77.37B$83.92B$109.91B$122.07B$112.07B$78.80B$76.39B$67.60B$57.62B$37.92B$36.43B$33.69B
Enterprise Value $99.93B$106.86B$128.50B$138.79B$130.22B$93.09B$91.54B$82.88B$73.94B$49.57B$50.18B$46.69B
P/E 13.914.418.721.118.617.916.418.515.715.614.914.0
P/S 0.40.50.60.80.80.60.70.70.60.40.50.5
P/B 1.82.02.83.43.12.42.42.42.21.51.61.4
P / Tangible Book 17.888.929.679.089.537.5······
P / Cash Flow 18.014.413.614.513.47.412.617.713.811.88.910.0
P / FCF 24.418.416.216.815.48.215.325.817.014.510.512.7
EV / EBITDA 11.411.512.513.714.812.415.315.317.710.310.610.6
EV / FCF 31.523.519.019.217.99.618.431.621.818.914.417.6
EV / Revenue 0.50.60.80.90.90.80.90.90.80.60.60.6
Dividend Yield 2.0%1.8%1.3%1.0%0.99%1.2%1.1%1.1%1.2%1.8%1.8%1.4%
Earnings Yield 7.2%7.0%5.3%4.7%5.4%5.6%6.1%5.4%6.4%6.4%6.7%7.1%
Payout Ratio 27.0%25.2%23.3%20.4%18.1%20.9%17.0%20.7%18.3%27.7%25.7%18.7%
Annual Payout $1.53B$1.51B$1.40B$1.23B$1.10B$954M$818M$776M$705M$684M$657M$481M

Najnowszy okres po lewej · wartości null pokazane jako ·

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

16
Wskaźnik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $199.12B $177.01B $171.34B $156.59B $138.64B
Marża Operacyjna % 3.6% 4.4% 5.0% 5.4% 5.4%
Zysk netto $5.66B $5.98B $5.99B $5.89B $6.16B
Rozwodniony EPS $25.21 $25.68 $25.22 $24.28 $24.95

Właściciele instytucjonalni (13F) 1 756 emitentów · $81.9B łącznie · Na dzień 30 września 2026

17

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Posiadacze 1 756
Wartość posiadanych akcji $81.9B
Nowe pozycje 264
Zamknięte pozycje 94
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
264 (+89 vs poprzedni kw.) 94 (-110 vs poprzedni kw.) 609 (+128 vs poprzedni kw.) 550 (-104 vs poprzedni kw.) +6.8M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
VANGUARD GROUP INC $8 069 492 034 23 019 518 9,86% Akcje
BlackRock, Inc. $7 344 424 106 18 991 090 8,97% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $5 436 729 233 14 058 204 6,64% Akcje
STATE STREET CORP $4 032 282 885 10 426 610 4,93% Akcje
WELLINGTON MANAGEMENT GROUP LLP $3 563 141 883 9 213 513 4,35% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $2 403 277 896 6 214 356 2,94% Akcje
Sanders Capital, LLC $2 252 711 532 5 825 024 2,75% Akcje
GEODE CAPITAL MANAGEMENT, LLC $1 990 239 599 5 166 124 2,43% Akcje
HARRIS ASSOCIATES L P $1 904 455 957 4 924 511 2,33% Akcje
Artisan Partners Limited Partnership $1 771 695 984 4 581 222 2,16% Akcje
Invesco Ltd. $1 637 504 097 4 234 231 2,00% Akcje
First Eagle Investment Management, LLC $1 619 701 186 4 188 196 1,98% Akcje
NORGES BANK $1 531 008 381 3 958 856 1,87% Akcje
Bank of New York Mellon Corp $1 246 348 719 3 222 787 1,52% Akcje
FMR LLC $1 211 103 818 3 131 652 1,48% Akcje
MORGAN STANLEY $1 007 728 234 2 605 764 1,23% Akcje
NORTHERN TRUST CORP $817 928 536 2 114 986 1,00% Akcje
CITIGROUP INC $810 919 703 2 096 863 0,99% Akcje
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779 725 026 2 016 200 0,95% Akcje
GOLDMAN SACHS GROUP INC $775 630 749 2 005 613 0,95% Akcje
Nuveen, LLC $769 539 548 1 989 863 0,94% Akcje
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $749 415 810 1 935 880 0,92% Akcje
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $737 324 542 2 518 615 0,90% Akcje
BANK OF AMERICA CORP /DE/ $698 537 689 1 806 267 0,85% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697 546 062 1 803 703 0,85% Akcje
Legal & General Group Plc $688 469 125 1 780 232 0,84% Akcje
Grantham, Mayo, Van Otterloo & Co. LLC $654 221 093 1 691 671 0,80% Akcje
Amundi $635 991 799 1 644 537 0,78% Akcje
DIMENSIONAL FUND ADVISORS LP $601 132 524 1 554 359 0,73% Akcje
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591 084 393 1 528 416 0,72% Akcje
EAGLE CAPITAL MANAGEMENT LLC $576 772 638 1 491 409 0,70% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511 706 827 1 323 163 0,63% Akcje
VANGUARD FIDUCIARY TRUST CO $461 498 831 1 193 336 0,56% Akcje
BAILLIE GIFFORD & CO $418 920 245 1 083 237 0,51% Akcje
JPMORGAN CHASE & CO $386 949 330 997 214 0,47% Akcje
Ruane, Cunniff & Goldfarb L.P. $378 839 935 979 598 0,46% Akcje
Brave Warrior Advisors, LLC $377 790 736 976 885 0,46% Akcje
Newport Trust Company, LLC $369 294 278 954 915 0,45% Akcje
DEUTSCHE BANK AG\ $364 707 273 943 054 0,45% Akcje
FRANKLIN RESOURCES INC $360 834 432 933 040 0,44% Akcje
1832 Asset Management L.P. $355 109 795 918 237 0,43% Akcje
CITADEL ADVISORS LLC $350 526 658 906 386 0,43% Akcje
Capital International Investors $290 732 899 751 772 0,36% Akcje
UBS Group AG $286 115 618 739 833 0,35% Akcje
ACR Alpine Capital Research, LLC $285 376 389 737 922 0,35% Akcje
MILLENNIUM MANAGEMENT LLC $281 369 666 727 561 0,34% Akcje
ROYAL BANK OF CANADA $268 753 000 694 935 0,33% Akcje
High Ground Investment Management LLP $262 939 273 679 904 0,32% Akcje
CANADA PENSION PLAN INVESTMENT BOARD $261 530 030 676 260 0,32% Akcje
Qube Research & Technologies Ltd $247 577 198 640 181 0,30% Akcje

Pokaż wszystkich 1 756 właścicieli instytucjonalnych →

Insiderzy spółki 95 insiderów · 57 dyrektorzy generalni · 37 dyrektorzy

19
Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Gail Boudreaux President and CEO 17 lipca 2026 P 171 976 2 0 $1 002 230
Brian T Griffin EVP & CEO, IngenioRx 3 maja 2018 M 15 863 0 0 $0
Angela F Braly Chair, President & CEO 1 marca 2012 A 476 503 0 0 $0
Brian A Sassi President & CEO Cons, EVP 7 czerwca 2011 S 60 825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP 20 maja 2010 M 44 107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP 4 kwietnia 2008 F 42 143 0 0 $0
Joan E Herman President & CEO Cons and EVP 7 grudnia 2007 S 30 369 0 0 $0
Mark Kaye EVP & CFO 2 marca 2026 A 32 037 0 0 $0
John E Gallina EVP & Chief Financial Officer 1 marca 2023 A 63 725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer 3 marca 2016 F 57 957 0 0 $0
David C Colby Vice Chairman, CFO & EVP 4 kwietnia 2007 F 343 071 0 0 $0
Thomas R Byrd President, Anthem Specialty 26 listopada 2004 A 26 580 0 0 $0
Michael D Houk President, National Accounts 4 listopada 2004 M 18 843 0 0 $0
John M Murphy President, Specialty Business 17 maja 2004 A 20 806 0 0 $0
Caroline S Matthews Chief Operating Officer 1 grudnia 2004 A 40 471 0 0 $0
Erin M Wessling EVP & Chief Legal Officer 3 września 2026 F 7 230 0 0 $0
Ryan R Craig EVP & Chief HR Officer 2 września 2026 F 6 530 0 0 $0
Ronald W Penczek CAO & Controller 12 czerwca 2026 S 3 740 0 2 $-765 958
Charles Morgan Kendrick JR EVP & President, Commercial 6 marca 2026 S 11 791 0 1 $-910 604
Peter D Haytaian EVP & Pres Carelon & CarelonRx 3 marca 2026 F 27 222 0 0 $0
Felicia F Norwood EVP &Chief Health Benefits Ofr 2 marca 2026 A 38 838 0 0 $0
Ratnakar Lavu EVP & Chief Digital Info Ofr 2 marca 2026 A 16 149 0 0 $0
Blair Williams Todt EVP, CLO & CAO 3 stycznia 2025 F 15 631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off 24 marca 2023 S 51 435 0 0 $0
Leah Stark EVP & CHRO 30 grudnia 2021 F 12 403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health 1 października 2021 F 5 107 0 0 $0
Patel Prakash R EVP & President, DBG 4 września 2021 F 17 230 0 0 $0
Thomas C Zielinski EVP & General Counsel 3 listopada 2020 M 17 910 0 0 $0
Craig E Samitt EVP & President, DBG 26 lipca 2018 M 17 274 0 0 $0
Joseph Swedish Executive Chairman 5 marca 2018 S 61 419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer 1 marca 2018 A 3 105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer 3 marca 2017 F 23 927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer 19 maja 2015 M 110 973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer 1 maja 2015 F 23 249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty 2 marca 2015 A 84 281 0 0 $0
Richard C Zoretic EVP, Gov Business Division 3 marca 2014 A 53 572 0 0 $0
John Cannon EVP, GC & Chief PAO 13 grudnia 2013 S 99 331 0 0 $0
Randal L Brown EVP & Chief HR Officer 4 września 2013 M 30 332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT 30 maja 2013 M 113 955 0 0 $0
Harlan A Levine EVP, CHS 31 sierpnia 2012 S 25 244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off 2 kwietnia 2012 A 45 237 0 0 $0
Miller Martin SVP & Chief Accounting Officer 1 marca 2011 A 29 329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer 5 listopada 2010 M 52 634 0 0 $0
Cynthia S Miller EVP & Chief Actuary 1 marca 2010 A 60 757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer 7 sierpnia 2009 M 13 658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer 3 marca 2008 A 25 710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary 22 stycznia 2008 S 39 265 0 0 $0
John S Watts JR EVP 7 grudnia 2007 S 108 311 0 0 $0
Marjorie W Dorr EVP 22 maja 2007 M 38 951 0 0 $0
Michael A Stocker EVP 23 października 2006 M 42 186 0 0 $0
Keith R Faller EVP 12 września 2006 M 83 290 0 0 $0
David S Helwig EVP 18 sierpnia 2006 M 55 055 0 0 $0
Thomas G Snead JR EVP 31 stycznia 2006 M 0 0 0 $0
Ronald J Ponder EVP 18 listopada 2005 M 55 313 0 0 $0
David R Frick EVP 12 maja 2005 S 58 241 0 0 $0
Michael L Smith EVP 18 lutego 2005 S 98 810 0 0 $0
Jane E Niederberger Senior Vice President and Chie 17 maja 2004 A 28 648 0 0 $0
Ramiro G Peru Dyrektor 17 lipca 2026 P 10 908 1 0 $366 050
Robert L Dixon JR Dyrektor 11 czerwca 2026 S 10 734 0 1 $-60 667
Bahija Jallal Dyrektor 13 maja 2026 A 5 351 0 0 $0
Antonio F Neri Dyrektor 13 maja 2026 A 5 488 0 0 $0
Susan D. Devore Dyrektor 13 maja 2026 A 4 065 0 0 $0
Amy Schulman Dyrektor 13 maja 2026 A 781 0 1 $-7 475
Ryan M. Schneider Dyrektor 13 maja 2026 A 7 163 0 0 $0
Deanna D Strable-Soethout Dyrektor 13 maja 2026 A 2 209 0 0 $0
Steven H Collis Dyrektor 13 maja 2026 A 4 202 1 0 $869 520
Lewis Hay III Dyrektor 13 maja 2026 A 12 070 0 0 $0
Kerry R Clark Dyrektor 14 maja 2025 A 9 640 0 0 $0
Elizebeth E Tallett Dyrektor 15 maja 2024 A 10 291 0 0 $0
Julie A Hill Dyrektor 20 maja 2021 S 31 213 0 0 $0
George A Schaefer JR Dyrektor 16 maja 2018 A 38 864 0 0 $0
William J Ryan Dyrektor 28 lipca 2016 S 27 149 0 0 $0
John H Short Dyrektor 14 maja 2014 A 2 981 0 0 $0
Warren Y Jobe Dyrektor 13 marca 2014 G 26 525 0 0 $0
Lenox D Baker JR MD Dyrektor 8 marca 2013 M 71 155 0 0 $0
Susan B Bayh Dyrektor 21 maja 2012 S 0 0 0 $0
Sheila P Burke Dyrektor 16 maja 2012 A 16 200 0 0 $0
Jackie M Ward Dyrektor 16 maja 2012 A 23 806 0 0 $0
William H T Bush Dyrektor 17 maja 2011 M 28 383 0 0 $0
William G Mays Dyrektor 17 maja 2011 A 19 878 0 0 $0
Donald W Riegle JR Dyrektor 16 maja 2011 M 3 894 0 0 $0
Jane G Pisano Dyrektor 10 maja 2010 M 3 692 0 0 $0
Victor S Liss Dyrektor 10 maja 2010 M 4 658 0 0 $0
Larry C Glasscock Dyrektor 25 lutego 2010 M 3 352 0 0 $0
John Zuccotti Dyrektor 20 maja 2009 A · 0 0 $0
Ben L Lytle Dyrektor 10 maja 2005 A 2 128 0 0 $0
Leonard D Schaeffer Dyrektor 10 maja 2005 A 1 041 024 0 0 $0
Allan B Hubbard Dyrektor 14 lutego 2005 M 0 0 0 $0
John Sherman JR Dyrektor 1 grudnia 2004 M 4 164 0 0 $0
James W Mcdowell JR Dyrektor 1 października 2004 A 1 271 0 0 $0
Dennis J Sullivan JR Dyrektor 26 lipca 2004 M 2 837 0 0 $0
Leeba Lessin · 1 marca 2013 A 15 451 0 0 $0
Rebecca A Kapustay · 1 kwietnia 2005 M 34 557 0 0 $0
SANDERS ELIZABETH A · 3 marca 2005 S 35 604 0 0 $0
William B Hart · 1 października 2004 A 439 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Posiadanie ETF-ów Posiadane przez 165 funduszy ETF

20

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
IHF · iShares Trust 7,53% 237 106 SH 11 września 2026 Dziennie
CVGD · Elevation Series Trust 3,56% 13 113 NS 31 lipca 2026 N-PORT
FDIV · EA Series Trust 1,95% 3 050 NS 31 lipca 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 1,65% 80 785 NS 31 lipca 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,64% 45 819 NS 31 lipca 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,61% 36 334 SH 5 października 2026 Dziennie
RPV · Invesco Exchange-Traded Fund Trust 1,56% 67 254 SH 5 października 2026 Dziennie
PWV · Invesco Exchange-Traded Fund Trust 1,47% 69 546 SH 5 października 2026 Dziennie
IYH · iShares Trust 1,46% 127 077 SH 11 września 2026 Dziennie
SRHQ · Elevation Series Trust 1,41% 7 981 NS 31 lipca 2026 N-PORT
IMCV · iShares Trust 1,22% 34 046 SH 11 września 2026 Dziennie
VHT · VANGUARD WORLD FUND 1,22% 645 908 SH 19 sierpnia 2026 Dziennie
FHLC · FIDELITY COVINGTON TRUST 1,19% 104 494 NS 31 lipca 2026 N-PORT
VMAX · Lattice Strategies Trust 1,18% 1 543 NS 31 lipca 2026 N-PORT
IXJ · iShares Trust 1,15% 114 143 SH 11 września 2026 Dziennie
REVS · Columbia ETF Trust I 1,12% 9 954 NS 31 lipca 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 1,00% 252 869 SH 5 października 2026 Dziennie
CURE · Direxion Shares ETF Trust 0,94% 4 273 NS 31 lipca 2026 N-PORT
NUDV · Nushares ETF Trust 0,92% 1 235 NS 31 lipca 2026 N-PORT
SYLD · Cambria ETF Trust 0,92% 24 249 NS 31 lipca 2026 N-PORT
ESMV · iShares Trust 0,91% 170 SH 11 września 2026 Dziennie
EQIN · Columbia ETF Trust I 0,86% 6 959 NS 31 lipca 2026 N-PORT
ROUS · Lattice Strategies Trust 0,74% 13 856 NS 31 lipca 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,73% 15 896 SH 19 sierpnia 2026 Dziennie
RECS · Columbia ETF Trust I 0,73% 112 966 NS 31 lipca 2026 N-PORT
VLUE · iShares Trust 0,71% 163 004 SH 11 września 2026 Dziennie
NULC · Nushares ETF Trust 0,69% 1 301 NS 31 lipca 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0,68% 3 202 NS 31 lipca 2026 N-PORT
FEUS · FlexShares Trust 0,61% 1 815 NS 31 lipca 2026 N-PORT
IMCB · iShares Trust 0,61% 24 486 SH 11 września 2026 Dziennie
FDLO · FIDELITY COVINGTON TRUST 0,60% 22 637 NS 31 lipca 2026 N-PORT
DIVB · iShares Trust 0,54% 26 159 SH 11 września 2026 Dziennie
IDRV · iShares Trust 0,53% 143 110 SH 11 września 2026 Dziennie
RDVI · First Trust Exchange-Traded Fund IV 0,52% 50 065 NS 31 lipca 2026 N-PORT
XOEF · iShares Trust 0,51% 273 SH 11 września 2026 Dziennie
IUS · Invesco Exchange-Traded Self-Indexe… 0,50% 12 654 SH 5 października 2026 Dziennie
FTA · First Trust Exchange-Traded AlphaDE… 0,49% 18 161 NS 31 lipca 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,47% 13 779 000 5 października 2026 Dziennie
BSCS · Invesco Exchange-Traded Self-Indexe… 0,45% 16 107 990 5 października 2026 Dziennie
SUSA · iShares Trust 0,45% 43 466 SH 11 września 2026 Dziennie
ACWV · iShares, Inc. 0,44% 35 074 SH 11 września 2026 Dziennie
QUVU · Hartford Funds Exchange-Traded Trust 0,42% 2 019 NS 31 lipca 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,42% 106 885 SH 5 października 2026 Dziennie
PALC · Pacer Funds Trust 0,42% 2 320 NS 31 lipca 2026 N-PORT
EVUS · iShares Trust 0,40% 3 683 SH 11 września 2026 Dziennie
MGV · VANGUARD WORLD FUND 0,39% 133 635 SH 19 sierpnia 2026 Dziennie
DFUV · Dimensional ETF Trust 0,38% 154 644 NS 31 lipca 2026 N-PORT
PFIG · Invesco Exchange-Traded Fund Trust … 0,38% 515 000 2 października 2026 Dziennie
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,37% 8 210 NS 31 lipca 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,37% 16 621 000 5 października 2026 Dziennie
USXF · iShares Trust 0,36% 12 883 SH 11 września 2026 Dziennie
DFLV · Dimensional ETF Trust 0,36% 65 144 NS 31 lipca 2026 N-PORT
VIG · VANGUARD SPECIALIZED FUNDS 0,36% 1 200 113 SH 19 sierpnia 2026 Dziennie
FHEQ · Fidelity Greenwood Street Trust 0,35% 8 603 NS 31 lipca 2026 N-PORT
VYM · VANGUARD WHITEHALL FUNDS 0,34% 847 792 SH 19 sierpnia 2026 Dziennie
CVY · Invesco Exchange-Traded Fund Trust 0,34% 1 030 SH 5 października 2026 Dziennie
IWX · iShares Trust 0,34% 31 304 SH 11 września 2026 Dziennie
USMV · iShares Trust 0,32% 181 462 SH 11 września 2026 Dziennie
BSCT · Invesco Exchange-Traded Self-Indexe… 0,31% 9 525 000 5 października 2026 Dziennie
DGRO · iShares Trust 0,31% 320 084 SH 11 września 2026 Dziennie
VTV · VANGUARD INDEX FUNDS 0,31% 2 021 174 SH 19 sierpnia 2026 Dziennie
PFM · Invesco Exchange-Traded Fund Trust 0,31% 6 186 SH 5 października 2026 Dziennie
IVE · iShares Trust 0,30% 360 968 SH 11 września 2026 Dziennie
ACIO · ETF Series Solutions 0,29% 18 049 NS 31 lipca 2026 N-PORT
IUSV · iShares Trust 0,29% 189 556 SH 11 września 2026 Dziennie
ADME · ETF Series Solutions 0,28% 2 222 NS 31 lipca 2026 N-PORT
HDUS · Lattice Strategies Trust 0,28% 1 531 NS 31 lipca 2026 N-PORT
ESG · FlexShares Trust 0,28% 990 NS 31 lipca 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0,28% 48 913 SH 19 sierpnia 2026 Dziennie
SUSL · iShares Trust 0,26% 7 654 SH 11 września 2026 Dziennie
FEX · First Trust Exchange-Traded AlphaDE… 0,26% 10 930 NS 31 lipca 2026 N-PORT
DSI · iShares Trust 0,26% 33 146 SH 11 września 2026 Dziennie
ILCV · iShares Trust 0,25% 8 135 SH 11 września 2026 Dziennie
FAB · First Trust Exchange-Traded AlphaDE… 0,24% 1 096 NS 31 lipca 2026 N-PORT
IWD · iShares Trust 0,24% 482 434 SH 11 września 2026 Dziennie
IQSU · New York Life Investments ETF Trust 0,24% 2 111 NS 31 lipca 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 0,24% 152 NS 31 lipca 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,23% 2 806 NS 31 lipca 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 0,23% 128 096 SH 19 sierpnia 2026 Dziennie
ESGG · FlexShares Trust 0,21% 627 NS 31 lipca 2026 N-PORT
EUSA · iShares, Inc. 0,21% 9 792 SH 11 września 2026 Dziennie
FYEE · Fidelity Greenwood Street Trust 0,21% 1 194 NS 31 lipca 2026 N-PORT
GLBL · Pacer Funds Trust 0,20% 6 NS 31 lipca 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,20% 490 516 SH 5 października 2026 Dziennie
ESGU · iShares Trust 0,19% 83 443 SH 11 września 2026 Dziennie
SIZE · iShares Trust 0,19% 1 938 SH 11 września 2026 Dziennie
USCL · iShares Trust 0,17% 11 477 SH 11 września 2026 Dziennie
TOPC · iShares Trust 0,17% 133 SH 11 września 2026 Dziennie
DFSU · Dimensional ETF Trust 0,16% 9 705 NS 31 lipca 2026 N-PORT
IWL · iShares Trust 0,16% 8 413 SH 11 września 2026 Dziennie
XVV · iShares Trust 0,15% 2 493 SH 11 września 2026 Dziennie
MGC · VANGUARD WORLD FUND 0,15% 42 364 SH 19 sierpnia 2026 Dziennie
QVML · Invesco Exchange-Traded Fund Trust … 0,15% 6 380 SH 5 października 2026 Dziennie
OMFL · Invesco Exchange-Traded Self-Indexe… 0,14% 17 682 SH 5 października 2026 Dziennie
ESGV · VANGUARD WORLD FUND 0,14% 47 980 SH 19 sierpnia 2026 Dziennie
IVV · iShares Trust 0,14% 2 737 349 SH 11 września 2026 Dziennie
ACVF · ETF Opportunities Trust 0,14% 548 NS 31 lipca 2026 N-PORT
ILCB · iShares Trust 0,13% 4 087 SH 11 września 2026 Dziennie
BKLC · BNY Mellon ETF Trust 0,13% 18 995 NS 31 lipca 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,13% 5 589 584 SH 19 sierpnia 2026 Dziennie
VV · VANGUARD INDEX FUNDS 0,13% 248 024 SH 19 sierpnia 2026 Dziennie
IWB · iShares Trust 0,13% 150 486 SH 11 września 2026 Dziennie
IYY · iShares Trust 0,13% 9 294 SH 11 września 2026 Dziennie
PBP · Invesco Exchange-Traded Fund Trust 0,13% 1 291 SH 5 października 2026 Dziennie
PTLC · Pacer Funds Trust 0,13% 11 007 NS 31 lipca 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,13% 35 097 SH 5 października 2026 Dziennie
IWV · iShares Trust 0,12% 59 652 SH 11 września 2026 Dziennie
ITOT · iShares Trust 0,12% 282 740 SH 11 września 2026 Dziennie
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,12% 28 858 NS 31 lipca 2026 N-PORT
VOTE · TCW ETF Trust 0,12% 3 538 NS 31 lipca 2026 N-PORT
VONE · VANGUARD SCOTTSDALE FUNDS 0,12% 35 020 SH 19 sierpnia 2026 Dziennie
TOV · EA Series Trust 0,12% 873 NS 31 lipca 2026 N-PORT
DFUS · Dimensional ETF Trust 0,12% 65 434 NS 31 lipca 2026 N-PORT
DXUV · Dimensional ETF Trust 0,12% 1 719 NS 31 lipca 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,12% 820 NS 31 lipca 2026 N-PORT
VOXP · Advisors Series Trust 0,12% 18 NS 31 lipca 2026 N-PORT
QDPL · Pacer Funds Trust 0,12% 5 228 NS 31 lipca 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,11% 6 834 097 SH 19 sierpnia 2026 Dziennie
VTHR · VANGUARD SCOTTSDALE FUNDS 0,11% 17 880 SH 19 sierpnia 2026 Dziennie
TOK · iShares Trust 0,11% 620 SH 11 września 2026 Dziennie
PHDG · Invesco Actively Managed Exchange-T… 0,11% 171 SH 5 października 2026 Dziennie
DFAC · Dimensional ETF Trust 0,11% 134 751 NS 31 lipca 2026 N-PORT
TILT · FlexShares Trust 0,10% 6 004 NS 31 lipca 2026 N-PORT
HCMT · Direxion Shares ETF Trust 0,10% 1 508 NS 31 lipca 2026 N-PORT
URTH · iShares, Inc. 0,10% 19 735 SH 11 września 2026 Dziennie
DCOR · Dimensional ETF Trust 0,10% 8 835 NS 31 lipca 2026 N-PORT
DFAU · Dimensional ETF Trust 0,10% 31 680 NS 31 lipca 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0,09% 16 978 NS 31 lipca 2026 N-PORT
GLOF · iShares Trust 0,09% 455 SH 11 września 2026 Dziennie
LGDX · Tidal Trust III 0,09% 342 NS 31 lipca 2026 N-PORT
ACWI · iShares Trust 0,09% 69 481 SH 11 września 2026 Dziennie
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 1 815 SH 5 października 2026 Dziennie
CRBN · iShares Trust 0,08% 2 188 SH 11 września 2026 Dziennie
NEAR · iShares U.S. ETF Trust 0,08% 3 886 000 SH 11 września 2026 Dziennie
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,07% 290 778 SH 19 sierpnia 2026 Dziennie
PICK · iShares, Inc. 0,06% 266 862 SH 11 września 2026 Dziennie
DFVX · Dimensional ETF Trust 0,05% 720 NS 31 lipca 2026 N-PORT
LRGF · iShares Trust 0,03% 2 746 SH 11 września 2026 Dziennie
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,03% 571 538 SH 19 sierpnia 2026 Dziennie
SCZ · iShares Trust 0,03% 625 241 SH 11 września 2026 Dziennie
PEVC · Pacer Funds Trust 0,02% 1 NS 31 lipca 2026 N-PORT
DYNF · BlackRock ETF Trust 0,01% 13 133 SH 11 września 2026 Dziennie
IPAC · iShares Trust 0,01% 52 224 SH 11 września 2026 Dziennie
VPL · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 158 652 SH 19 sierpnia 2026 Dziennie
WSML · iShares Trust 0,01% 9 378 SH 11 września 2026 Dziennie
IEFA · iShares Trust 0,00% 1 291 652 SH 11 września 2026 Dziennie
IDEV · iShares Trust 0,00% 211 325 SH 11 września 2026 Dziennie
IXUS · iShares Trust 0,00% 168 378 SH 11 września 2026 Dziennie
VXUS · VANGUARD STAR FUNDS 0,00% 2 181 735 SH 19 sierpnia 2026 Dziennie
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 1 468 301 SH 19 sierpnia 2026 Dziennie
VSGX · VANGUARD WORLD FUND 0,00% 30 111 SH 19 sierpnia 2026 Dziennie
BIV · VANGUARD BOND INDEX FUNDS · · 15 lipca 2026 Dziennie
BLV · VANGUARD BOND INDEX FUNDS · · 15 lipca 2026 Dziennie
BSV · VANGUARD BOND INDEX FUNDS · · 15 lipca 2026 Dziennie
BND · VANGUARD BOND INDEX FUNDS · · 15 lipca 2026 Dziennie
VUSB · VANGUARD BOND INDEX FUNDS · · 15 lipca 2026 Dziennie
VCRB · VANGUARD MALVERN FUNDS · · 15 lipca 2026 Dziennie
VPLS · VANGUARD MALVERN FUNDS · · 15 lipca 2026 Dziennie
VSDB · VANGUARD MALVERN FUNDS · · 15 lipca 2026 Dziennie
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 lipca 2026 Dziennie
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 lipca 2026 Dziennie
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 lipca 2026 Dziennie
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 lipca 2026 Dziennie
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 lipca 2026 Dziennie
VCEB · VANGUARD WORLD FUND · · 30 lipca 2026 Dziennie

ELV Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

21
ocena · 29 analityków KUP
Średni cel $460.00 +15,0%
7 24,1% Mocne kupno
12 41,4% Kup
10 34,5% Trzymaj
0 0,0% Sprzedaj
0 0,0% Mocna sprzedaż

12-miesięczny cel cenowy

21 analityków · 2026-10-01

Średnia cel $451.38 +12,8%

Teraz Aktualna cena $400.09
Niski$393.00 Średnia$451.38 Wysoki$492.00

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

22

Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
ELV $77.37B 13.9 12.5% 2.8% 13.3% ·
UNH $299.08B 25.0 11.8% 2.7% 12.0% ·
HUM $50.90B 26.0 10.1% 0.92% 7.0% ·
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9% ·
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
CLOV · -5.1 40.3% -4.5% -26.2% ·
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%
ALHC $4.03B · 46.1% -0.02% -0.52% ·

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

23

Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku

25

Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

26

Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Źródło: SEC 10-Q złożone Lip 15, 2026